• Je něco špatně v tomto záznamu ?

Porovnání minimální extrakorporální cirkulace a aortokoronárního bypassu bez použití mimotělního oběhu
[Prospective randomized comparison of coronary bypass grafting with minimal extracorporeal circulation system (MECC) versus off-pump coronary surgery]

Mazzei V, et al.

. 2008 ; 2 (1) : 3.

Jazyk čeština Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07506375

We aimed to evaluate the clinical results and biocompatibility of the minimal extracorporeal circulation system (MECC) compared with off-pump coronary revascularization (OPCABG). METHODS AND RESULTS: In a prospective randomized study, 150 patients underwent coronary surgery with the use of MECC and 150 underwent OPCABG. End points were (1) circulating markers of inflammation and organ injury, (2) operative results, and (3) outcome at 1-year follow-up. Operative mortality and morbidity were comparable between the groups. Release of inflammatory markers was similar between groups at all time points (peak interleukin-6 167.2+/-13.5 versus 181+/-6.5 pg/mL, P=0.14, OPCABG versus MECC group, respectively). Peak creatine kinase was 419.3+/-103.5 versus 326+/-84.2 mg/dL (P=0.28), and peak S-100 protein was 0.13+/-0.08 versus 0.29+/-0.1 pg/mL (P=0.058, OPCABG versus MECC group, respectively). Length of hospital stay and use of blood products were similar between groups. Two cases of angina recurrence at 1 year in the MECC group were observed versus 5 cases observed in the OPCABG group (P=0.44). A residual perfusion defect at myocardial nuclear scan was less frequent among patients in the MECC group (3 versus 9 cases, P=0.14; odds ratio 0.32, 95% confidence interval 0.07 to 1.32). Six (OPCABG group) versus 3 (MECC group) coronary grafts were occluded or severely stenotic at 1 year (P=0.33, odds ratio 0.47, 95% confidence interval 0.09 to 2.14). CONCLUSIONS: Clinical results of coronary revascularization with MECC are optimal when this procedure is performed by experienced teams. Postoperative morbidity is comparable to that with OPCABG. MECC is associated with little pump-related systemic and organ injury. It may achieve the benefits of OPCABG (less morbidity in high-risk patients) while facilitating complete revascularization in the case of complex lesions unsuitable for OPCABG.

Prospective randomized comparison of coronary bypass grafting with minimal extracorporeal circulation system (MECC) versus off-pump coronary surgery

000      
04151naa 2200481 a 4500
001      
bmc07506375
003      
CZ-PrNML
005      
20111210122606.0
008      
080708s2008 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Mazzei, V.
245    10
$a Porovnání minimální extrakorporální cirkulace a aortokoronárního bypassu bez použití mimotělního oběhu / $c Mazzei V, et al.
246    11
$a Prospective randomized comparison of coronary bypass grafting with minimal extracorporeal circulation system (MECC) versus off-pump coronary surgery
314    __
$a Division of Cardiac Surgery, Ospedale Papardo, Messina
520    9_
$a We aimed to evaluate the clinical results and biocompatibility of the minimal extracorporeal circulation system (MECC) compared with off-pump coronary revascularization (OPCABG). METHODS AND RESULTS: In a prospective randomized study, 150 patients underwent coronary surgery with the use of MECC and 150 underwent OPCABG. End points were (1) circulating markers of inflammation and organ injury, (2) operative results, and (3) outcome at 1-year follow-up. Operative mortality and morbidity were comparable between the groups. Release of inflammatory markers was similar between groups at all time points (peak interleukin-6 167.2+/-13.5 versus 181+/-6.5 pg/mL, P=0.14, OPCABG versus MECC group, respectively). Peak creatine kinase was 419.3+/-103.5 versus 326+/-84.2 mg/dL (P=0.28), and peak S-100 protein was 0.13+/-0.08 versus 0.29+/-0.1 pg/mL (P=0.058, OPCABG versus MECC group, respectively). Length of hospital stay and use of blood products were similar between groups. Two cases of angina recurrence at 1 year in the MECC group were observed versus 5 cases observed in the OPCABG group (P=0.44). A residual perfusion defect at myocardial nuclear scan was less frequent among patients in the MECC group (3 versus 9 cases, P=0.14; odds ratio 0.32, 95% confidence interval 0.07 to 1.32). Six (OPCABG group) versus 3 (MECC group) coronary grafts were occluded or severely stenotic at 1 year (P=0.33, odds ratio 0.47, 95% confidence interval 0.09 to 2.14). CONCLUSIONS: Clinical results of coronary revascularization with MECC are optimal when this procedure is performed by experienced teams. Postoperative morbidity is comparable to that with OPCABG. MECC is associated with little pump-related systemic and organ injury. It may achieve the benefits of OPCABG (less morbidity in high-risk patients) while facilitating complete revascularization in the case of complex lesions unsuitable for OPCABG.
650    _2
$a senioři $7 D000368
650    _2
$a kardiopulmonální bypass $x metody $x mortalita $7 D002315
650    _2
$a koronární bypass $x metody $x mortalita $7 D001026
650    _2
$a koronární bypass bez mimotělního oběhu $x mortalita $7 D047549
650    _2
$a nemoci koronárních tepen $x chirurgie $x mortalita $7 D003324
650    _2
$a kreatinkinasa $x krev $7 D003402
650    _2
$a mimotělní oběh $x metody $x mortalita $7 D005112
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a interleukin-6 $x krev $7 D015850
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pooperační komplikace $x mortalita $7 D011183
650    _2
$a prospektivní studie $7 D011446
650    _2
$a proteiny S100 $x krev $7 D009418
650    _2
$a analýza přežití $7 D016019
773    0_
$w MED00012706 $t Clinical cardiology alert $g Roč. 2, č. 1 (2008), s. 3 $x 1213-2586
910    __
$a ABA008 $b B 2242 $c 407 a $y 1
990    __
$a 20080708110723 $b ABA008
991    __
$a 20080708131304 $b ABA008
999    __
$a ok $b bmc $g 622000 $s 474433
BAS    __
$a 3
BMC    __
$a 2008 $b 2 $c 1 $d 3 $i 1213-2586 $m Clinical Cardiology Alert $x MED00012706
LZP    __
$a 2008-7/mkme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...